Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma

eLife

Volumn 4, Issue NOVEMBER2015, 2015, Pages

  Grosso, Ana R ^a   Leite, Ana P ^a   Carvalho, Sílvia ^a   Matos, Mafalda R ^a   Martins, Filipa B ^a   Vítor, Alexandra C ^a   Desterro, Joana M P ^a   Carmo Fonseca, Maria ^a   de Almeida, Sérgio F ^a  

^a UNIVERSITY OF LISBON   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN BCL 2; RNA; RNA POLYMERASE II; TRANSCRIPTOME; VON HIPPEL LINDAU PROTEIN; BCL2 PROTEIN, HUMAN; HISTONE LYSINE METHYLTRANSFERASE; HYBRID PROTEIN; MESSENGER RNA; ONCOPROTEIN; SET2 PROTEIN, HUMAN;

ARTICLE; CHIMERA; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENHANCER REGION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; ONCOGENE; PBRM1 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA ISOLATION; SET DOMAIN CONTAINING 2 GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; BIOSYNTHESIS; GENETIC RECOMBINATION; GENETICS; KIDNEY TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CARCINOMA, RENAL CELL; CELL LINE, TUMOR; GENE EXPRESSION; GENE EXPRESSION PROFILING; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; KIDNEY NEOPLASMS; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT FUSION PROTEINS; RECOMBINATION, GENETIC; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84958191482     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.09214     Document Type: Article

References (26)

1. Cancer Genome Atlas Research N. 2013. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499:43-49. doi: 10.1038/nature12222.
2. Carvalho S, Vı´tor AC, Sridhara SC, Martins FB, Raposo AC, Desterro JMP, Ferreira J, de Almeida SF. 2014. SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint. eLife 3: e02482. doi: 10.7554/eLife.02482.
3. Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Gordon Robertson A, Chu A, Beroukhim R, Cibulskis K, Signoretti S, Vandin Hsin-Tawu F, Raphael BJ, Verhaak RGW, Tamboli P, Torres-Garcia W, Akbani R, Weinstein JN, Reuter V, Hsieh JJ, Rose Brannon A, Ari Hakimi A, Jacobsen A, Ciriello G, Reva B, Ricketts CJ, Marston Linehan W, Stuart JM, Kimryn Rathmell W, Shen H, Laird PW, Muzny D, Davis C, Morgan M, Xi L, Chang K, Kakkar N, Treviño LR, Benton S, Reid JG, Morton D, Doddapaneni H, Han Y, Lewis L, Dinh H, Kovar C, Zhu Y, Santibanez J, Wang M, Hale W, Kalra D, Creighton CJ, Wheeler DA, Gibbs RA, Getz G, Cibulskis K, Lawrence MS, Sougnez C, Carter SL, Sivachenko A, Lichtenstein L, Stewart C, Voet D, Fisher Sheila, Gabriel Stacey B., Lander E, Beroukhim R, Schumacher Steve E., Tabak B, Saksena Gordon, Onofrio RC, Carter SL, Cherniack AD, Gentry Jeff, Ardlie K, Sougnez Carrie, Getz G, Gabriel SB, Meyerson M, Gordon Robertson A, Chu A, Chun H-JE, Mungall AJ, Sipahimalani P, Stoll D, Ally A, Balasundaram M, Butterfield YSN, Carlsen R, Carter C, Chuah E, Coope RJN, Dhalla N, Gorski S, Guin R, Hirst C, Hirst M, Holt RA, Lebovitz C, Lee D, Li HI, Mayo M, Moore RA, Pleasance E, Plettner P, Schein JE, Shafiei A, Slobodan JR, Tam A, Thiessen N, Varhol RJ, Wye N, Zhao Y, Birol I, Jones SJM, Marra MA, Auman JT, Tan D, Jones CD, Hoadley KA, Mieczkowski PA, Mose LE, Jefferys SR, Topal MD, Liquori C, Turman YJ, Shi Y, Waring S, Buda E, Walsh J, Wu J, Bodenheimer T, Hoyle AP, Simons JV, Soloway MG, Balu S, Parker JS, Neil Hayes D, Perou CM, Kucherlapati R, Park P, Shen H, Triche T, Weisenberger DJ, Lai PH, Bootwalla MS, Maglinte DT, Mahurkar S, Berman BP, Van Den Berg DJ, Cope L, Baylin SB, Laird PW, Creighton CJ, Wheeler DA, Getz G, Noble MS, DiCara D, Zhang H, Cho J, Heiman DI, Gehlenborg N, Voet D, Mallard W, Lin P, Frazer S, Stojanov P, Liu Y, Zhou L, Kim J, Lawrence MS, Chin L, Vandin F, Wu H-T, Raphael BJ, Benz C, Yau C, Reynolds SM, Shmulevich I, Verhaak RGW, Torres-Garcia W, Vegesna R, Kim H, Zhang W, Cogdell D, Jonasch E, Ding Z, Lu Y, Akbani R, Zhang N, Unruh AK, Casasent TD, Wakefield C, Tsavachidou D, Chin L, Mills GB, Weinstein JN, Jacobsen A, Rose Brannon A, Ciriello G, Schultz N, Ari Hakimi A, Reva B, Antipin Y, Gao J, Cerami E, Gross B, Arman Aksoy B, Sinha R, Weinhold N, Onur Sumer S, Taylor BS, Shen R, Ostrovnaya I, Hsieh JJ, Berger MF, Ladanyi M, Sander C, Fei SS, Stout A, Spellman PT, Rubin DL, Liu TT, Stuart JM, Ng S, Paull EO, Carlin D, Goldstein T, Waltman P, Ellrott K, Zhu J, Haussler D, Gunaratne PH, Xiao W, Shelton C, Gardner J, Penny R, Sherman M, Mallery D, Morris S, Paulauskis J, Burnett K, Shelton T, Signoretti S, Kaelin WG, Choueiri T, Atkins MB, Penny R, Burnett K, Mallery D, Curley E, Tickoo S, Reuter V, Kimryn Rathmell W, Thorne L, Boice L, Huang M, Fisher JC, Marston Linehan W, Vocke CD, Peterson J, Worrell R, Merino MJ, Schmidt LS, Tamboli P, Czerniak BA, Aldape KD, Wood CG, Boyd J, Weaver J, Iacocca MV, Petrelli N, Witkin G, Brown J, Czerwinski C, Huelsenbeck-Dill L, Rabeno B, Myers J, Morrison C, Bergsten J, Eckman J, Harr J, Smith C, Tucker K, Anne Zach L, Bshara W, Gaudioso C, Morrison C, Dhir R, Maranchie J, Nelson J, Parwani A, Potapova O, Fedosenko K, Cheville JC, Houston Thompson R, Signoretti S, Kaelin WG, Atkins MB, Tickoo S, Reuter V, Marston Linehan W, Vocke CD, Peterson J, Merino MJ, Schmidt LS, Tamboli P, Mosquera JM, Rubin MA, Blute ML, Kimryn Rathmell W, Pihl T, Jensen M, Sfeir R, Kahn A, Chu A, Kothiyal P, Snyder E, Pontius J, Ayala B, Backus M, Walton J, Baboud J, Berton D, Nicholls M, Srinivasan D, Raman R, Girshik S, Kigonya P, Alonso S, Sanbhadti R, Barletta S, Pot D, Sheth M, Demchok JA, Davidsen T, Wang Z, Yang L, Tarnuzzer RW, Zhang J, Eley G, Ferguson ML, Mills Shaw KR, Guyer MS, Ozenberger BA, Sofia HJ. The Cancer Genome Atlas Research Network Awg BCoM. 2013. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499:43-49. doi: 10.1038/nature12222.
4. Dalgliesh GL, Furge K, Greenman C, Chen L, Bignell G, Butler A, Davies H, Edkins S, Hardy C, Latimer C, Teague J, Andrews J, Barthorpe S, Beare D, Buck G, Campbell PJ, Forbes S, Jia M, Jones D, Knott H, Kok CY, Lau KW, Leroy C, Lin M-L, McBride DJ, Maddison M, Maguire S, McLay K, Menzies A, Mironenko T, Mulderrig L, Mudie L, O’Meara S, Pleasance E, Rajasingham A, Shepherd R, Smith R, Stebbings L, Stephens P, Tang G, Tarpey PS, Turrell K, Dykema KJ, Khoo SK, Petillo D, Wondergem B, Anema J, Kahnoski RJ, Teh BT, Stratton MR, Futreal PA. 2010. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 463:360-363. doi: 10.1038/nature08672.
5. de Almeida SF, Grosso AR, Koch F, Fenouil R, Carvalho S, Andrade J, Levezinho H, Gut M, Eick D, Gut I, Andrau J-C, Ferrier P, Carmo-Fonseca M. 2011. Splicing enhances recruitment of methyltransferase HYPB/Setd2 and methylation of histone H3 Lys36. Nature Structural & Molecular Biology 18:977-983. doi: 10.1038/nsmb.2123.
6. Duns G, van den Berg E, van Duivenbode I, Osinga J, Hollema H, Hofstra RMW, Kok K. 2010. Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinoma. Cancer Research 70:4287-4291. doi: 10.1158/0008-5472.CAN-10-0120.
7. Dye MJ, Proudfoot NJ. 1999. Terminal exon definition occurs cotranscriptionally and promotes termination of RNA polymerase II. Molecular Cell 3:371-378. doi: 10.1016/S1097-2765(00)80464-5.
8. Gingeras TR. 2009. Implications of chimaeric non-co-linear transcripts. Nature 461:206-211. doi: 10.1038/nature08452.
9. Higgs DR, Goodbourn SEY, Lamb J, Clegg JB, Weatherall DJ, Proudfoot NJ. 1983. a-thalassaemia caused by a polyadenylation signal mutation. Nature 306:398-400. doi: 10.1038/306398a0.
10. Ho TH, Park IY, Zhao H, Tong P, Champion MD, Yan H, Monzon FA, Hoang A, Tamboli P, Parker AS, Joseph RW, Qiao W, Dykema K, Tannir NM, Castle EP, Nunez-Nateras R, Teh BT, Wang J, Walker CL, Hung M-C, Jonasch E. 2015. High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma. Oncogene. doi: 10.1038/onc.2015.221.
11. Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, Xie M, Zhang Q, McMichael JF, Wyczalkowski MA, Leiserson MDM, Miller CA, Welch JS, Walter MJ, Wendl MC, Ley TJ, Wilson RK, Raphael BJ, Ding L. 2013. Mutational landscape and significance across 12 major cancer types. Nature 502:333-339. doi: 10.1038/nature12634.
12. Karolchik D, Barber GP, Casper J, Clawson H, Cline MS, Diekhans M, Dreszer TR, Fujita PA, Guruvadoo L, Haeussler M, Harte RA, Heitner S, Hinrichs AS, Learned K, Lee BT, Li CH, Raney BJ, Rhead B, Rosenbloom KR, Sloan CA, Speir ML, Zweig AS, Haussler D, Kuhn RM, Kent WJ. 2014. The UCSC genome browser database: 2014 update. Nucleic Acids Research 42:D764-D770. doi: 10.1093/nar/gkt1168.
13. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. 2013. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biology 14:R36. doi: 10.1186/gb-2013-14-4-r36.
14. Kim D, Salzberg SL. 2011. TopHat-fusion: an algorithm for discovery of novel fusion transcripts. Genome Biology 12:R72. doi: 10.1186/gb-2011-12-8-r72.
15. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, Jones SJ, Marra MA. 2009. Circos: an information aesthetic for comparative genomics. Genome Research 19:1639-1645. doi: 10.1101/gr.092759.109.
16. Kuehner JN, Pearson EL, Moore C. 2011. Unravelling the means to an end: RNA polymerase II transcription termination. Nature Reviews Molecular Cell Biology 12:283-294. doi: 10.1038/nrm3098.
17. Luco RF, Pan Q, Tominaga K, Blencowe BJ, Pereira-Smith OM, Misteli T. 2010. Regulation of alternative splicing by histone modifications. Science 327:996-1000. doi: 10.1126/science.1184208.
18. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. 2008. Mapping and quantifying mammalian transcriptomes by RNA-seq. Nature Methods 5:621-628. doi: 10.1038/nmeth.1226.
19. Niwa M, MacDonald CC, Berget SM. 1992. Are vertebrate exons scanned during splice-site selection? Nature 360:277-280. doi: 10.1038/360277a0.
20. Proudfoot NJ. 1986. Transcriptional interference and termination between duplicated a-globin gene constructs suggests a novel mechanism for gene regulation. Nature 322:562-565. doi: 10.1038/322562a0.
21. Quinlan AR, Hall IM. 2010. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26:841-842. doi: 10.1093/bioinformatics/btq033.
22. Team RDC. 2011. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
23. Uchida T, Gao J-P, Wang C, Satoh T, Itoh I, Muramoto M, Hyodo T, Irie A, Akahoshi T, Jiang S-X, Kameya T, Baba S. 2001. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice. Molecular Urology 5:71-78. doi: 10.1089/109153601300177583.
24. Varela I, Tarpey P, Raine K, Huang D, Ong CK, Stephens P, Davies H, Jones D, Lin M-L, Teague J, Bignell G, Butler A, Cho J, Dalgliesh GL, Galappaththige D, Greenman C, Hardy C, Jia M, Latimer C, Lau KW, Marshall J, McLaren S, Menzies A, Mudie L, Stebbings L, Largaespada DA, Wessels LFA, Richard S, Kahnoski RJ, Anema J, Tuveson D, Perez-Mancera PA, Mustonen V, Fischer A, Adams DJ, Rust A, Chanon W, Subimerb C, Dykema K, Furge K, Campbell PJ, Teh BT, Stratton MR, Futreal PA. 2011. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469:539-542. doi: 10.1038/nature09639.
25. Zack TI, Schumacher SE, Carter SL, Cherniack AD, Saksena G, Tabak B, Lawrence MS, Zhang C-Z, Wala J, Mermel CH, Sougnez C, Gabriel SB, Hernandez B, Shen H, Laird PW, Getz G, Meyerson M, Beroukhim R. 2013. Pan-cancer patterns of somatic copy number alteration. Nature Genetics 45:1134-1140. doi: 10.1038/ng.2760.
26. Zhang Y, Xie S, Zhou Y, Xie Y, Liu P, Sun M, Xiao H, Jin Y, Sun X, Chen Z, Huang Q, Chen S. 2014. H3K36 histone methyltransferase Setd2 is required for murine embryonic stem cell differentiation toward endoderm. Cell Reports 8:1989-2002. doi: 10.1016/j.celrep.2014.08.031.